Analysed ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) News Sources
Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
12-05-2026
yahoo.com
Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting
21-05-2026
yahoo.com
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
30-05-2026
yahoo.com
What is the current price of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)?
The current price of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) is $0.
ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) since the previous trading day is $None.
ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)?
The most recent average sentiment score for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) is 54 out of 100.
What is the most recent average sentiment for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)?
The most recent sentiment for ORION OYJ-UNSPON ADR (ORINY:OTCMKTS) is .
SEC-8K** Filing Available For ORION OYJ-UNSPON ADR (ORINY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.